Moscow, 11 April, 2008 – OJSC Pharmstandard (LSE: PHST LI, RTS: PHST RU), the leading domestic pharmaceutical company in Russia and the third largest pharmaceutical company operating in Russia overall, announces that Russian Federal Commission of Securities Markets has granted its permission for additional 1 889 628 ordinary shares of the Company to float outside of Russian Federation. This Shares representing approximately 5% of Pharmstandard’s outstanding Shares.

This FCSM permission could be used by major Pharmstandard shareholder Augment Investments Limited as additional mechanism of financing potential M&A deals. The shareholder plans to be flexible in financial instruments selection and does not announce any time for this permission realization.

Currently 25% of Shares in form of global depository receipts (“GDRs”) float on London Stock Exchange.